| Net loss | -2.33M |
| Depreciation and amortization | 342.89K |
| Share-based compensation | 1.42M |
| Realized loss on available for sale securities | |
| Accounts receivable | 4.28K |
| Prepaid expenses and other assets | -135.28K |
| Accounts payable and accrued expenses | -2.9M |
| Deferred rent | |
| Deferred revenue | -64 |
| Total adjustments | -552.18K |
| Net cash used in operating activities | |
| Purchase of investments available for sale | -2.4M |
| Proceeds from sale of investments | 1.98M |
| Payments for patent costs and other intangible assets | |
| Purchases of property and equipment | |
| Net cash (used in) provided by investing activities | |
| Net proceeds from issuance of common stock in public and private offerings | |
| Net proceeds from exercise of options and warrants | 422.5K |
| Principal payments on capital lease obligation | -419 |
| Net cash (used in) provided by financing activities | |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | -1.08M |
| CASH AND CASH EQUIVALENTS, beginning of period | 1.54M |
| CASH AND CASH EQUIVALENTS, end of period | 463.96K |